Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Apr 18, 2021 6:26pm
103 Views
Post# 33019679

RE:RE:RE:Board chair at ONC

RE:RE:RE:Board chair at ONCSo Jeff's counsel to me is to vote two board members off to send a message - thanks for that feedback. Anyone else want to offer some advice? If this were to be effective, it would help to have some agreement on who those two board members should be, although we are all free agents here and can vote however we like. At this point I would guess Lacoste and Littlejohn would be the most likely for us to focus on if we went this direction, but feel free to make other suggestions. And please be aware, I am not even committing to voting anyone off the board at this point. I am just looking for the combined wisdom of the group knowing that I may well be sitting on the swing votes. There is a very good chance I will disappoint the most disgruntled shareholders with how I vote the shares I control but those of you wanting even stronger action than Jeff has suggested still have time to sway me. 

I will be thinking about any ideas any of you would like to share and then I will let you know my final thoughts at some point prior to the annual meeting, long enough before it so that all can consider their own positions in light of the advice offered here and make their own choices while having sufficient time to get them mailed in so they will count. I do not recommend waiting until the actual meeting to vote as one never knows if the technology will work. Remember last year, the technology crashed and we did not even get to hear the speeches of the Chairwoman and CEO. So, don't count on that. Also, for English speakers, it is possible the AGM will be conducted completely in French, so that could make it difficult to know when it is appropriate to vote online or what the discussion was before the vote. Voting early by mail or online makes the most sense.  
 
Ideally, none of that is even necessary and we can get it all sorted out in a friendly fashion soon. Wino seems like he would be a great person to speak with the company to discuss the best way forward but he has to want to do that too. And, obviosuly, no one would be required to follow whatever the result of his efforts were anyway - it would just be guidance for how we might want to vote based on whatever came of his/her discussions with management (I know nothing about Wino other than his/her nickname). And if Wino demurs, we will need another volunteer to step up, so lplease be thinking about that too. We should be able to resolve this amicably, but one never knows how people will react, or overreact, to situations like this. 

jeffm34 wrote:

No I don't have a legal background.  I don't think a special meeting is needed right now. If we do in fact have the numbers to vote out 1 or 2 board members this go around that's all that's needed. Remove 2 board members and let it be known if credible changes aren't made quickly then a special meeting will be called with a full slate of new board members proposed.  The board is responsible for executive compensation so if we show we have the ability to change the board, you can be sure changes will be made. 

 

SPCEO1 wrote: Jeffm34 - I believe you were the one who posted some info about calling a special meeting at one point. Do you have some legal background or did you just work hard to dig that info up? If you are a legal type - do you anything about what might happen if you got your wish and shareholders voted many sitting board members off the board? I am assuming the remaining board members would be able to replace those who were voted off with new board members of their choosing and potentially no effective chage from our perspective. Or is there some other way for shareholders to have a bigger say in who those replacements might be?
 

 

jeffm34 wrote: Here's a small company from Alberta, Canada specializing in oncology.  They don't have one of several thousand ex-vps from Pfizer sitting on their board. Their board chair is Wayne Pisano who is the former president and CEO of Sanofi Pasteur.  TH refuses to look outside its small circle of friends for any help what so ever.  Nothing will change with the stock performance until that mindset is completely erased from the company. 

 




<< Previous
Bullboard Posts
Next >>